Birzeit Pharmaceuticals Company (PEX:BPC)

Palestine flag Palestine · Delayed Price · Currency is JOD · Price in USD
3.980
+0.180 (4.74%)
At close: May 27, 2025
0.25%
Market Cap 109.37M
Revenue (ttm) 29.63M
Net Income (ttm) 5.64M
Shares Out 38.76M
EPS (ttm) 0.14
PE Ratio 20.42
Forward PE n/a
Dividend 0.04 (1.26%)
Ex-Dividend Date Apr 23, 2025
Volume 82,001
Average Volume 6,269
Open 3.800
Previous Close 3.800
Day's Range 3.700 - 3.980
52-Week Range 3.550 - 4.350
Beta -0.02
RSI 58.93
Earnings Date May 15, 2025

About PEX:BPC

Birzeit Pharmaceuticals Company manufactures and trades in various medicines in the Palestinian Authority. The company offers its products in various therapeutic fields comprising alimentary system, cardio-vascular system, muscolo-skeletal system, endocrines, central nervous system, genito-urinary system, obstetrics and gynecology, infections, dermatological preparations, ophthalmic drugs, respiratory system, and nutrition and metabolism, as well as ear, nose, and oropharynx. It also provides OTC products, such as multivitamins and minerals, an... [Read more]

Industry Pharmaceutical Preparations
Founded 1973
Employees 300
Stock Exchange Palestine Stock Exchange
Ticker Symbol BPC
Full Company Profile

Financial Performance

In 2024, PEX:BPC's revenue was $40.65 million, a decrease of -5.74% compared to the previous year's $43.13 million. Earnings were $5.18 million, a decrease of -15.26%.

Financial numbers in USD Financial Statements

News

There is no news available yet.